5 things to know about Zurzuvae, the first postpartum depression pill : NPR

Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.

Related Keywords

United States ,Massachusetts ,American ,Ruta Nonacs ,Kristina Deligiannidis ,Tiffany Farchione ,Jamille Nagtalon Ramos ,Hospital Center ,Maternal Mental Health ,Division Of Psychiatry ,Drug Administration ,Biogen Inc ,Women Mental Health ,Centers For Disease ,Postpartum Support International ,Rutgers University ,Getty Images ,Sage Therapeutics ,Policy Center ,Joy Burkhard ,Disease Control ,Drug Evaluation ,Crisis Lifeline ,Crisis Text Line ,All Things ,Rescue Plan Act ,Massachusetts General Hospital Center ,